Publications
48
Citations
493
Est. group size
—
Recurring co-author estimate
Active years
18
Publishing since 2009
Jennifer A. Belsky studies cancers in children, adolescents, and young adults, with a particular focus on Hodgkin lymphoma and other lymphomas as well as acute leukemia. Much of her work examines treatment strategies and supportive care, including managing side effects like chemotherapy-induced nerve damage (peripheral neuropathy) and infections, often through multi-institution studies with the Children's Oncology Group. She also investigates biomarkers linked to cognitive and nerve-related effects of chemotherapy.
Publication activity has grown steadily over the past decade, rising from roughly one paper per year to a recent average of about 6.6 papers per year.
Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026
- Neurofilament Light Chain: A Potential Biomarker for Chemotherapy-Induced Peripheral Neuropathy in Adolescent Young Adults
Journal of Adolescent and Young Adult Oncology · 2026
- Patterns of presentation and outcomes in stage <scp>IV</scp> Hodgkin lymphoma: A report from the Children's Oncology Group ( <scp>COG</scp> ) <scp>AHOD1331</scp> trial
British Journal of Haematology · 2026
- Practice patterns in the diagnosis and management of chemotherapy-induced peripheral neuropathy in adolescents and young adults with cancer: a survey of oncologists
Supportive Care in Cancer · 2025
- Inflammatory and oxidative stress biomarkers associated with cognitive function in patients with Hodgkin lymphoma treated with chemotherapy
Blood · 2025
- Current Treatment Strategies and Supportive Care Practices in the Care of Children and Adolescents With Mature B‐Cell Non‐Hodgkin Lymphoma: A Survey of Children's Oncology Group Institutions
Pediatric Blood & Cancer · 2025
- Prevention and Management of Infectious Complications in Pediatric Patients With Cancer: A Survey Assessment of Current Practices Across Children's Oncology Group Institutions
Pediatric Blood & Cancer · 2025
- Pediatric relapsed/refractory ALK-positive anaplastic large cell lymphoma treatment and outcomes in the targeted-drug era
Blood Advances · 2025
- Evaluation of the Childhood Hodgkin International Prognostic Score (CHIPS) in High‐Risk Pediatric Hodgkin Lymphoma Patients Treated on Children's Oncology Group AHOD1331
Pediatric Blood & Cancer · 2025
- Delayed excretion of high‐dose methotrexate in pediatric acute leukemia correlates with laxative and constipation management
Pediatric Blood & Cancer · 2024
- Protocol-Stipulated Dose Modification to Manage Chemotherapy-Induced Peripheral Neuropathy in Children, Adolescents, and Young Adults With High-Risk Hodgkin Lymphoma
JCO Oncology Practice · 2024
- The pediatric approach to Hodgkin lymphoma
Seminars in Hematology · 2024
- Advances in Pediatric Hodgkin Lymphoma with an Eye on Disparities and Vulnerable Populations
Hematology/Oncology Clinics of North America · 2023
- Diagnosis and management of Hodgkin lymphoma in children, adolescents, and young adults
Best Practice & Research Clinical Haematology · 2023
- An International Survey Investigating the Incidence and Management of Brown Fat Uptake on<sup>18</sup>F-FDG PET/CT at Children’s Hospitals and Interventions for Mitigation
Journal of Nuclear Medicine Technology · 2023
- Late effects and frontline treatment selection for children with non-Hodgkin lymphoma
Best Practice & Research Clinical Haematology · 2023
- Pediatric Blood & Cancer×12
- Blood×4
- Journal of Osteopathic Medicine×3
- Best Practice & Research Clinical Haematology×2
- Journal of Adolescent and Young Adult Oncology×2
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 11, 2026.
Claim or correct this profile